Balchem Co. (NASDAQ:BCPC) Position Boosted by Summit Investment Advisors Inc.

Summit Investment Advisors Inc. increased its holdings in Balchem Co. (NASDAQ:BCPC) by 3.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,382 shares of the basic materials company’s stock after purchasing an additional 107 shares during the quarter. Summit Investment Advisors Inc.’s holdings in Balchem were worth $551,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. HighTower Advisors LLC grew its holdings in shares of Balchem by 15.3% in the 3rd quarter. HighTower Advisors LLC now owns 2,229 shares of the basic materials company’s stock worth $391,000 after acquiring an additional 295 shares during the last quarter. Stifel Financial Corp raised its holdings in Balchem by 26.2% during the 3rd quarter. Stifel Financial Corp now owns 11,893 shares of the basic materials company’s stock worth $2,093,000 after buying an additional 2,467 shares during the period. Barclays PLC boosted its holdings in shares of Balchem by 405.8% in the third quarter. Barclays PLC now owns 60,777 shares of the basic materials company’s stock worth $10,695,000 after buying an additional 48,762 shares during the period. Westside Investment Management Inc. purchased a new position in shares of Balchem in the third quarter worth approximately $27,000. Finally, Wilmington Savings Fund Society FSB acquired a new stake in shares of Balchem during the third quarter valued at approximately $35,000. 87.91% of the stock is currently owned by institutional investors.

Balchem Price Performance

Shares of NASDAQ:BCPC opened at $161.50 on Friday. The business has a fifty day simple moving average of $164.84 and a 200 day simple moving average of $167.72. The company has a current ratio of 1.99, a quick ratio of 1.16 and a debt-to-equity ratio of 0.19. Balchem Co. has a 1 year low of $137.69 and a 1 year high of $186.03. The firm has a market cap of $5.25 billion, a price-to-earnings ratio of 41.09, a P/E/G ratio of 4.41 and a beta of 0.75.

Balchem (NASDAQ:BCPC) last announced its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 EPS for the quarter, missing the consensus estimate of $1.11 by ($0.08). The firm had revenue of $240.00 million during the quarter, compared to the consensus estimate of $239.96 million. Balchem had a net margin of 13.47% and a return on equity of 11.37%. As a group, sell-side analysts predict that Balchem Co. will post 4.64 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have weighed in on the stock. Sidoti upgraded shares of Balchem to a “hold” rating in a research report on Tuesday, February 25th. StockNews.com lowered Balchem from a “buy” rating to a “hold” rating in a research report on Tuesday, February 25th. Finally, HC Wainwright reaffirmed a “buy” rating and set a $190.00 target price on shares of Balchem in a research note on Monday, February 24th.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.